AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations.

Cancer-initiating translocations such as those associated with lymphomas require the formation of paired DNA double-strand breaks (DSBs). Activation-induced cytidine deaminase (AID) produces widespread somatic mutation in mature B cells; however, the extent of "off-target" DSB formation and its role in translocation-associated malignancy is unknown. Here, we show that deregulated expression of AID causes widespread genome instability, which alone is insufficient to induce B cell lymphoma; transformation requires concomitant loss of the tumor suppressor p53. Mature B cell lymphomas arising as a result of deregulated AID expression are phenotypically diverse and harbor clonal reciprocal translocations involving a group of Immunoglobulin (Ig) and non-Ig genes that are direct targets of AID. This group includes miR-142, a previously unknown micro-RNA target that is translocated in human B cell malignancy. We conclude that AID produces DSBs throughout the genome, which can lead to lymphoma-associated chromosome translocations in mature B cells.

[1]  Vasco M. Barreto,et al.  Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Lieber,et al.  Mechanistic aspects of lymphoid chromosomal translocations. , 2008, Journal of the National Cancer Institute. Monographs.

[3]  Sergio Roa,et al.  The biochemistry of somatic hypermutation. , 2008, Annual review of immunology.

[4]  D. Robbiani,et al.  Maintained rules of development in a mouse B-cell tumor , 2005, Leukemia.

[5]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[6]  H. Inagaki.  Mucosa‐associated lymphoid tissue lymphoma: Molecular pathogenesis and clinicopathological significance , 2007, Pathology international.

[7]  M. Nussenzweig,et al.  AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc/IgH Translocations , 2008, Cell.

[8]  F. Alt,et al.  Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice , 2009, Proceedings of the National Academy of Sciences.

[9]  Samuel H. Wilson,et al.  Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase. , 2004, The Journal of clinical investigation.

[10]  S. Akira,et al.  Contribution of Receptor Editing to the Antibody Repertoire , 2007 .

[11]  M. Neuberger,et al.  Molecular mechanisms of antibody somatic hypermutation. , 2007, Annual review of biochemistry.

[12]  G. Teng,et al.  Immunoglobulin somatic hypermutation. , 2007, Annual review of genetics.

[13]  M. Schlissel,et al.  Leukemia and lymphoma: a cost of doing business for adaptive immunity. , 2006, Genes & development.

[14]  L. Pasqualucci,et al.  AID is required for germinal center–derived lymphomagenesis , 2008, Nature Genetics.

[15]  P. Nowell,et al.  Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Vasco M. Barreto,et al.  The role of activation-induced deaminase in antibody diversification and chromosome translocations. , 2007, Advances in immunology.

[17]  Michel C. Nussenzweig,et al.  Role of genomic instability and p53 in AID-induced c-myc–Igh translocations , 2006, Nature.

[18]  C. E. Schrader,et al.  Mechanism and regulation of class switch recombination. , 2008, Annual review of immunology.

[19]  V(D)J Recombination , 2002 .

[20]  M. Nussenzweig,et al.  Antigen receptor diversification and chromosome translocations , 2007, Nature Immunology.

[21]  Vasco M. Barreto,et al.  Somatic Hypermutation Is Limited by CRM1-dependent Nuclear Export of Activation-induced Deaminase , 2004, The Journal of experimental medicine.

[22]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[23]  B. Chait,et al.  Regulation of class switch recombination and somatic mutation by AID phosphorylation , 2008, The Journal of experimental medicine.

[24]  S. Tonegawa,et al.  Somatic generation of antibody diversity. , 1976, Nature.

[25]  Michel C Nussenzweig,et al.  MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. , 2008, Immunity.

[26]  M. Qumsiyeh,et al.  No Requirement for V(D)J Recombination in p53-Deficient Thymic Lymphoma , 1998, Molecular and Cellular Biology.

[27]  N. Kakazu,et al.  Constitutive Expression of AID Leads to Tumorigenesis , 2003, The Journal of experimental medicine.

[28]  M. Nussenzweig,et al.  Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Lowe,et al.  Intrinsic tumour suppression , 2004, Nature.

[30]  D. Schatz,et al.  Two levels of protection for the B cell genome during somatic hypermutation , 2008, Nature.

[31]  T. Rabbitts,et al.  Commonality but Diversity in Cancer Gene Fusions , 2009, Cell.

[32]  N. Carter,et al.  Ultra-high resolution array painting facilitates breakpoint sequencing , 2006, Journal of Medical Genetics.

[33]  D. Schatz,et al.  Identification of an AID-independent pathway for chromosomal translocations between the Igh switch region and Myc , 2004, Nature Immunology.

[34]  W. Peters.  Chemotherapy of Rodent Malaria. , 1981 .

[35]  F. Alt,et al.  53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination , 2004, Nature Immunology.

[36]  J. Langhorne,et al.  Role of gamma interferon during infection with Plasmodium chabaudi chabaudi , 1990, Infection and immunity.

[37]  L. Staudt,et al.  Decision making in the immune system: Lymphoid Malignancies: the dark side of B-cell differentiation , 2002, Nature Reviews Immunology.

[38]  L. Staudt,et al.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Lieber,et al.  Human Chromosomal Translocations at CpG Sites and a Theoretical Basis for Their Lineage and Stage Specificity , 2008, Cell.

[40]  Ryan T. Phan,et al.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells , 2004, Nature.

[41]  F. Alt,et al.  Histone H2AX A Dosage-Dependent Suppressor of Oncogenic Translocations and Tumors , 2003, Cell.

[42]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[43]  Thomas Tuschl,et al.  MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. , 2008, Immunity.

[44]  W. Peters,et al.  The chemotherapy of rodent malaria. LVIII. Drug combinations to impede the selection of drug resistance, Part. 2: The new generation--artemisinin or artesunate with long-acting blood schizontocides. , 2000, Annals of tropical medicine and parasitology.

[45]  M. Nussenzweig,et al.  A role for AID in chromosome translocations between c-myc and the IgH variable region , 2007, Journal of Experimental Medicine.

[46]  M. Nussenzweig,et al.  53BP1 is required for class switch recombination , 2004, The Journal of cell biology.

[47]  M. Greaves,et al.  Origins of chromosome translocations in childhood leukaemia , 2003, Nature Reviews Cancer.

[48]  T. Ried,et al.  AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements , 2007, The Journal of experimental medicine.

[49]  M. Potter.  Neoplastic development in plasma cells , 2003, Immunological reviews.

[50]  U. Storb,et al.  Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. , 1998, Science.

[51]  K. Manova,et al.  Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models , 2005, Nature Cell Biology.

[52]  L. Pasqualucci,et al.  BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Lieber,et al.  Roles of nonhomologous DNA end joining, V(D)J recombination, and class switch recombination in chromosomal translocations. , 2006, DNA repair.

[54]  M. Nussenzweig,et al.  ATM Prevents the Persistence and Propagation of Chromosome Breaks in Lymphocytes , 2007, Cell.

[55]  Riccardo Dalla-Favera,et al.  Mechanisms of chromosomal translocations in B cell lymphomas , 2001, Oncogene.

[56]  M. Nussenzweig,et al.  AID Is Required for c-myc/IgH Chromosome Translocations In Vivo , 2004, Cell.

[57]  Alexandre Orthwein,et al.  Active nuclear import and cytoplasmic retention of activation-induced deaminase , 2009, Nature Structural &Molecular Biology.

[58]  F. Alt,et al.  Mechanisms promoting translocations in editing and switching peripheral B cells , 2009, Nature.

[59]  F. Alt,et al.  AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development , 2008, The Journal of experimental medicine.

[60]  F. Alt,et al.  Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences. , 2005, Advances in immunology.

[61]  M. Nussenzweig,et al.  Switching on chromosomal translocations. , 2006, Cancer research.

[62]  T. Honjo,et al.  Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.

[63]  F. Alt,et al.  The Mechanism and Regulation of Chromosomal V(D)J Recombination , 2002, Cell.

[64]  Thomas Ried,et al.  AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching , 2001, Nature.

[65]  M. Neuberger,et al.  AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification , 2002, Nature.

[66]  Wei Gu,et al.  Modes of p53 Regulation , 2009, Cell.

[67]  D. Green,et al.  Cytoplasmic functions of the tumour suppressor p53 , 2009, Nature.

[68]  T. Honjo,et al.  Molecular mechanism of class switch recombination: linkage with somatic hypermutation. , 2002, Annual review of immunology.

[69]  Yoshimasa Tanaka,et al.  Negative regulation of activation-induced cytidine deaminase in B cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Kevin M. McBride,et al.  Expression of AID transgene is regulated in activated B cells but not in resting B cells and kidney. , 2008, Molecular immunology.

[71]  Ralf Küppers,et al.  Mechanisms of B-cell lymphoma pathogenesis , 2005, Nature Reviews Cancer.

[72]  B. Hoffman,et al.  Apoptotic signaling by c-MYC , 2008, Oncogene.

[73]  T. Ried,et al.  Chimeric IgH-TCRα/δ translocations in T lymphocytes mediated by RAG , 2009 .

[74]  M. Nussenzweig,et al.  ATM Is Required for Efficient Recombination between Immunoglobulin Switch Regions , 2004, The Journal of experimental medicine.